Description

[1,2,5]Oxadiazolo[3,4-B]Quinoxaline,5,6,7,8-Tetrahydro-(9Ci) is a heterocyclic organic compound of significant interest in advanced materials and pharmaceutical research. This specialized chemical serves as a critical building block and intermediate for synthesizing complex molecules with unique electronic and biological properties. It is primarily utilized by research scientists and process development chemists in the pharmaceutical, agrochemical, and material science industries for developing novel compounds.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting neurological and oncological pathways.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its heterocyclic structure for biological activity.
• Organic Electronic Materials: Serves as a core component in the research and development of organic semiconductors, light-emitting diodes (OLEDs), and other optoelectronic devices.
• Coordination Chemistry & Ligand Synthesis: Acts as a chelating ligand or precursor for creating metal-organic frameworks (MOFs) and catalysts.
• Dye & Pigment Intermediate: Utilized in the synthesis of specialized dyes and high-performance pigments due to its fused ring system.
• Academic & R&D Laboratories: Employed in fundamental chemical research to study heterocyclic chemistry, reaction mechanisms, and structure-activity relationships.

Basic Information

Product Name	[1,2,5]Oxadiazolo[3,4-B]Quinoxaline,5,6,7,8-Tetrahydro-(9Ci)
CAS No.	67200-32-2
Molecular Formula	C8H6N4O
Molecular Weight	174.16 g/mol
Synonyms	5,6,7,8-Tetrahydro-[1,2,5]oxadiazolo[3,4-b]quinoxaline; [1,2,5]Oxadiazolo[3,4-b]quinoxaline, 5,6,7,8-tetrahydro-; Tetrahydro[1,2,5]oxadiazolo[3,4-b]quinoxaline; 1,2,5-Oxadiazolo[3,4-b]quinoxaline, 5,6,7,8-tetrahydro-; 5,6,7,8-Tetrahydro-1,2,5-oxadiazolo[3,4-b]quinoxaline; 67200-32-2; Furo[2,3-f]quinoxaline, 4,5,6,7-tetrahydro- (related); Contact for additional IUPAC names and research codes.
EINECS	Contact for details

Quality Control

Our [1,2,5]Oxadiazolo[3,4-B]Quinoxaline,5,6,7,8-Tetrahydro-(9Ci) is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity for research and development applications. Our products undergo rigorous quality testing to ensure compliance with industry standards. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maximize stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95% (Research Grade)
Purity (HPLC)	≥ 98% (Premium Grade)
Melting Point	Contact for details
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.